Literature DB >> 7005119

Serological and immunohistological studies on lepromatous leprosy.

K Kano, N Aranzazu, T Nishimaki, J Convit, B Albini, F Milgrom.   

Abstract

Sera of patients with lepromatous leprosy were studied for the presence of a variety of antibodies and immune complexes (IC). The frequencies of heterophile, Hanganutziu-Deicher and Forssman antibodies were 61 and 43%, respectively, which were significantly higher than those in other diseases. The frequency of antibodies to cardiolipin was 89% and the frequency of rheumatoid factor was 34%. Circulating IC were demonstrated in 54% of the patients' sera by Raji-cell test and in 43% by anti-antibody inhibition test. Analyses of immunoglobulin classes of IC revealed that IgG was predominant in IC of patients with lepra reaction (LR) and IgM in patients without LR. Immune deposits were found in and between cells of dermis in skin biopsy specimens of patients with LR.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7005119     DOI: 10.1159/000232670

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  4 in total

1.  Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy.

Authors:  G Bothamley; J S Beck; W Britton; A Elsaghier; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

2.  Associations of circulating immune complexes, clinical activity, and bacterial index in Japanese patients with leprosy.

Authors:  F Furukawa; M Ozaki; S Imamura; H Yoshida; A Pinrat; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

3.  Immunological studies on Kawasaki disease. I. Appearance of Hanganutziu-Deicher antibodies.

Authors:  M Takiguchi; T Tamura; M Goto; S Kusakawa; F Milgrom; K Kano
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

4.  Immunohistological studies of skin biopsies from patients with lepromatous leprosy.

Authors:  R N Mshana; D P Humber; A Belehu; M Harboe
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.